Carvacrol Ameliorates Ligation‐Induced Periodontitis in Rats
- 1 July 2017
- journal article
- Published by Wiley in Journal of Periodontology
- Vol. 88 (7) , e120-e128
Abstract
Background: This study aims to evaluate the ameliorative effect of carvacrol, an anti‐inflammatory monoterpenoid phenol and a major component of Plectranthus amboinicus, on periodontal damage in an experimental rat model of periodontitis.Methods: Forty Sprague‐Dawley rats were divided into ligation (Lig), non‐ligation (n‐Lig), and two ligation plus carvacrol (Lig+C) groups. Carvacrol (17.5 or 35.0 mg/kg body weight/day) was administered intragastrically from 1 day before ligation. On day 8, dental alveolar bone loss and gingival inflammation in periodontal specimens were examined by dental radiography, microcomputed tomography, and histology. Expressions of tumor necrosis factor‐α, interleukin (IL)‐1β, IL‐6, and inducible nitric oxide synthase messenger (m)RNAs, and levels of matrix metalloproteinase (MMP)‐2 and MMP‐9 in gingiva were examined by reverse transcription‐polymerase chain reaction and zymography.Results: Dental radiography revealed periodontal bone‐supporting ratios in Lig and Lig+C groups were lower than the n‐Lig group, with Lig group ratios being lowest. Compared with the n‐Lig group, the cemento‐enamel junction–bone distance was significantly longer in Lig and Lig+C groups, with Lig+C groups showing shorter distances regardless of radiographic methods used. Histology and histometry showed less inflammatory area and stronger connective tissue attachment in Lig+C groups than in the Lig group. Cytokine/mediator mRNA expression and MMP‐9 levels were reduced in the Lig+C groups.Conclusions: Carvacrol reduced tissue damage and bone loss caused by ligation‐induced periodontitis. The present results indicate that carvacrol might reduce tissue destruction by downregulating expression of proinflammatory mediators and MMP‐9.Keywords
This publication has 44 references indexed in Scilit:
- Use of polyphenols in periodontal inflammationEuropean Journal of Pharmacology, 2013
- Matrix metalloproteinases and periodontal diseasesOral Diseases, 2013
- Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010Journal of Natural Products, 2012
- Gingival crevicular fluid levels of MMP‐8, MMP‐9, TIMP‐2, and MPO decrease after periodontal therapyJournal of Clinical Periodontology, 2010
- Cytokines That Promote Periodontal Tissue DestructionJournal of Periodontology, 2008
- Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1β, TNF-α and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPSInnate Immunity, 2008
- Cytokine Profiling of Macrophages Exposed toPorphyromonas gingivalis, Its Lipopolysaccharide, or Its FimA ProteinInfection and Immunity, 2005
- The role of inflammatory mediators in the pathogenesis of periodontal diseaseJournal of Periodontal Research, 1991
- Nature of periodontal diseases: Pathogenic mechanismsJournal of Periodontal Research, 1987
- Clinical trials in periodontal therapyJournal of Periodontal Research, 1987